Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium
Article
Mehta, MP, Rodrigus, P, Terhaard, CH et al. (2001). Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium
. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 51(3), 135-136. 10.1016/s0360-3016(01)02070-3
Mehta, MP, Rodrigus, P, Terhaard, CH et al. (2001). Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium
. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 51(3), 135-136. 10.1016/s0360-3016(01)02070-3